Kinnov Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kinnov Therapeutics SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11074
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company provides pipeline product such as KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors is used in the treatment of arterial high blood pressurel; and antagonist of 5HT2 and 5HT1C receptors are used in the treatment of allergy. Kinnova’s preclinical research and development addiction include identifying the key receptors of addictions, selecting compounds inhibiting these receptors, developing a therapeutic composition for human and validating the concept on proper animal models. The company partners with pharma company to conduct phase III studies for its pipeline product. Kinnov is headquartered in Orleans, France.

Kinnov Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Kinnov Therapeutics to Raise USD1.7 Million in Venture Financing 10
Kinnov Therapeutics Raises USD0.1 Miillion in Venture Financing 11
Licensing Agreements 12
Kinnov Therapeutics Enters into Licensing Agreement with Greenpharma 12
Kinnov Therapeutics SAS – Key Competitors 13
Kinnov Therapeutics SAS – Key Employees 14
Kinnov Therapeutics SAS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Key Facts 2
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kinnov Therapeutics SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kinnov Therapeutics to Raise USD1.7 Million in Venture Financing 10
Kinnov Therapeutics Raises USD0.1 Miillion in Venture Financing 11
Kinnov Therapeutics Enters into Licensing Agreement with Greenpharma 12
Kinnov Therapeutics SAS, Key Competitors 13
Kinnov Therapeutics SAS, Key Employees 14

List of Figures
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kinnov Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Kinnov Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Midatech Pharma Plc (MTPH)-医療機器分野:企業M&A・提携分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercialize oncology and other therapeutic products. The company’s products include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It conducts research and development programs in areas of oncology, …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • FANCL Corporation:企業の戦略・SWOT・財務情報
    FANCL Corporation - Strategy, SWOT and Corporate Finance Report Summary FANCL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報
    Summary BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple …
  • BOC Group Life Assurance Company Limited:企業の戦略・SWOT・財務情報
    BOC Group Life Assurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary BOC Group Life Assurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • The Toro Company:企業の戦略・SWOT・財務分析
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Hut Group Ltd:企業のM&A・事業提携・投資動向
    The Hut Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hut Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • SES SA (SESG):企業の財務・戦略的SWOT分析
    SES SA (SESG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Pepsi-Cola Products Philippines Inc:戦略・SWOT・企業財務分析
    Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • CKE Restaurants Holdings Inc.:企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Solvay SA (SOLB):電力:M&Aディール及び事業提携情報
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates. In addition, the company manufactures additives, engineering plastics, diphenols an …
  • Kezar Life Sciences Inc (KZR):製薬・医療:M&Aディール及び事業提携情報
    Summary Kezar Life Sciences Inc (Kezar Life Sciences) is a clinical-stage biotechnology company that discovers and develops small molecule therapies to treat autoimmunity and cancer. The company’s lead product candidate, KZR-616, an immunoproteasome inhibitor intended for the treatment of various au …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Astaldi Spa
    Astaldi Spa - Strategy, SWOT and Corporate Finance Report Summary Astaldi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Huron Consulting Group Inc
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Coesia S.p.A.:戦略・SWOT・企業財務分析
    Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆